Consun Pharmaceutical Group Limited (HKG:1681)
14.84
+0.19 (1.30%)
Sep 30, 2026, 4:08 PM HKT
HKG:1681 Market Cap
HKG:1681 has a market cap or net worth of 12.45 billion as of October 1, 2026. Its market cap has decreased by -8.48% in one year.
Market Cap
12.45B
Enterprise Value
8.42B
Revenue
4.19B
Ranking
n/a
PE Ratio
9.31
Stock Price
14.84
ChartMarket Cap Chart
Since December 19, 2013, HKG:1681's market cap has increased from 4.90B to 12.45B, an increase of 154.11%. That is a compound annual growth rate of 7.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 12.45B | -5.23% |
| Dec 31, 2025 | 13.14B | 94.05% |
| Dec 31, 2024 | 6.77B | 79.14% |
| Dec 29, 2023 | 3.78B | 18.38% |
| Dec 30, 2022 | 3.19B | -8.64% |
| Dec 31, 2021 | 3.49B | 43.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CanSino Biologics | 18.58B |
| Grand Pharmaceutical Group | 17.26B |
| The United Laboratories International Holdings | 15.67B |
| Fujian Haixi Pharmaceuticals | 13.07B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Shandong Xinhua Pharmaceutical Company | 9.70B |
| SSY Group | 8.17B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 7.97B |